Edgewise Therapeutics (EWTX) Gets a Buy from Wedbush
In a report released today, Laura Chico from Wedbush maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price ...
Wedbush Keeps Their Buy Rating on Astria Therapeutics (ATXS)
Wedbush analyst Laura Chico maintained a Buy rating on Astria Therapeutics (ATXS – Research Report) today and set a price target of $28.00. The ...
As Trump poses with Teslas in front of the White House, the company’s slumping stock climbs
It was almost an extraordinary scene in front of the White House. As Tesla shares have been tanking since the year began, President Donald Trump held remarks outside of the White House with the ...
The Tesla deadline Elon Musk needs to hit
Tesla's lower-cost vehicle is supposed to begin production by June at the latest. Analysts tell BI the launch is "crucial" ...
Trump's Efforts to Help Tesla Could Hurt It Instead
Musk pumped $270 million into Trump's campaign heading into the 2024 election, appeared on stage with him and cheered Trump's ...
With the stock cut in half, Tesla investors want their CEO back
"It's become clear he's now spending more time on DOGE than anything else," said one analyst of Elon Musk.